AU2002365256A1 - Gemcitabine in the treatment of smallpox - Google Patents

Gemcitabine in the treatment of smallpox

Info

Publication number
AU2002365256A1
AU2002365256A1 AU2002365256A AU2002365256A AU2002365256A1 AU 2002365256 A1 AU2002365256 A1 AU 2002365256A1 AU 2002365256 A AU2002365256 A AU 2002365256A AU 2002365256 A AU2002365256 A AU 2002365256A AU 2002365256 A1 AU2002365256 A1 AU 2002365256A1
Authority
AU
Australia
Prior art keywords
smallpox
gemcitabine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365256A
Other versions
AU2002365256A8 (en
Inventor
John Irvin Glass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002365256A1 publication Critical patent/AU2002365256A1/en
Publication of AU2002365256A8 publication Critical patent/AU2002365256A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
AU2002365256A 2001-10-25 2002-10-15 Gemcitabine in the treatment of smallpox Abandoned AU2002365256A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35662301P 2001-10-25 2001-10-25
US60/356,623 2001-10-25
PCT/US2002/031570 WO2003059334A2 (en) 2001-10-25 2002-10-15 Gemcitabine in the treatment of smallpox

Publications (2)

Publication Number Publication Date
AU2002365256A1 true AU2002365256A1 (en) 2003-07-30
AU2002365256A8 AU2002365256A8 (en) 2003-07-30

Family

ID=23402228

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365256A Abandoned AU2002365256A1 (en) 2001-10-25 2002-10-15 Gemcitabine in the treatment of smallpox

Country Status (2)

Country Link
AU (1) AU2002365256A1 (en)
WO (1) WO2003059334A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895937A (en) * 1982-01-05 1990-01-23 The Research Foundation Of State University Of New York 5-ioso-2-pyrimidinone nucleoside
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs

Also Published As

Publication number Publication date
WO2003059334A2 (en) 2003-07-24
WO2003059334A3 (en) 2003-10-30
AU2002365256A8 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
AU2002258990A1 (en) Improvements in ablation therapy
AU2003283257A1 (en) Scalp treatment
AU2002359500A1 (en) Fabric treatment composition
AU2002302570A1 (en) Hair treatment compositions
AU2002343312A1 (en) Two fixed-beams tx-diversity
GB0108671D0 (en) Skin treatment
AU2001260834A1 (en) The treatment of herpes
AU2002319286A1 (en) Skin treatment
AU2002335667A1 (en) Modified reoviral therapy
AU2002342865A1 (en) Hair treatment compositions
AU2002310922A1 (en) Interferons in the treatment of ischemia
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002365256A1 (en) Gemcitabine in the treatment of smallpox
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002318186A1 (en) Novel human kielin-like proteins and polynucleotides encoding the same
AU2002354842A1 (en) Novel human proton-gated channels
AU2002316943A1 (en) Hair treatment composition
AUPR814901A0 (en) Water treatment
AU2002256735A1 (en) Hair treatment compositions
AU2002308074A1 (en) Skin treatment
GB0130694D0 (en) Treatment
AU2002100788A4 (en) Water treatment
GB0122061D0 (en) Vision therapy
AU2002257630A1 (en) Human mrp5-like protein
AU2002310606A1 (en) Surface treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase